Diffuse alveolar hemorrhage with pseudoprogression during nivolumab therapy in a patient with malignant melanoma

Nivolumab, an anti‐PD‐1 antibody, has been shown to be effective in many cancers, such as malignant melanoma and lung cancer; however, nivolumab therapy can result in pseudoprogression. Diffuse alveolar hemorrhage (DAH) is persistent or recurrent pulmonary hemorrhage as a result of drugs, autoimmune...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Takaya, Yamaguchi, Hiroyuki, Dotsu, Yosuke, Taniguchi, Hirokazu, Gyoutoku, Hiroshi, Senju, Hiroaki, Sakamoto, Noriho, Iwanaga, Satoshi, Kuwatsuka, Yutaka, Fukuda, Minoru, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209794/
https://www.ncbi.nlm.nih.gov/pubmed/30253076
http://dx.doi.org/10.1111/1759-7714.12872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209794/
https://www.ncbi.nlm.nih.gov/pubmed/30253076
http://dx.doi.org/10.1111/1759-7714.12872

Ejemplares similares